SEARCH

SEARCH BY CITATION

References

  • Anand, M., Chodda, S.K., Parikh, P.M. & Nadkarni, J.S. (1998) Dysregulated cytokine production by monocytes from chronic lymphocytic leukemia patients. Cancer Biotherapy and Radiopharmaceuticals, 13, 4348.
  • Bartik, M.M., Welker, D. & Kay, N.E. (1998) Impairments in immune cell function in B cell chronic lymphocytic leukemia. Seminars in Oncology, 25, 2733.
  • Bendandi, M., Gocke, C.D., Kobrin, C.B., Benko, F.A., Sternas, L.A., Pennington, R., Watson, T.M., Reynolds, C.W., Gause, B.L., Duffey, P.L., Jaffe, E.S., Creekmore, S.P., Longo, D.L. & Kwak, L.W. (1999) Complete molecular remissions induced by patient-specific vaccination plus granulocyte-monocyte colony-stimulating factor against lymphoma. Nature Medicine, 5, 11711177.
  • Bluestone, J.A. (1995) New perspectives of CD28-B7-mediated T cell costimulation. Immunity, 2, 555559.
  • Boussiotis, V.A., Freeman, G.J., Gray, G., Gribben, J. & Nadler, L.M. (1993) B7 but not intercellular adhesion molecule-1 costimulation prevents the induction of human alloantigen-specific tolerance. Journal of Experimental Medicine, 178, 17531763.
  • Catovsky, D. & Foà, R. (1990) The Lymphoid Leukemias. Butterworths & Co LTD, UK, pp. 73112.
  • Cordone, I., Masi, S., Mauro, F.R., Soddu, S., Morsilli, O., Valentini, T., Vegna, M.L., Guglielmi, C., Mancini, F., Giuliacci, S., Sacchi, A., Mandelli, F. & Foa, R. (1998) p53 expression in B-cell chronic lymphocytic leukemia: a marker of disease progression and poor prognosis. Blood, 91, 43424349.
  • Cortellazzo, S., Viero, P., Barbui, T., Colucci, M. & Semeraro, N. (1983) Impaired production of mononuclear cell procoagulant activity in chronic lymphocytic leukaemia. Journal of Clinical Pathology, 36, 3740.
  • Criel, A., Verhoef, G., Vlietinck, R., Mecucci, C., Billiet, J., Michaux, L., Meeus, P., Louwagie, A., Van Orshoven, A., Van Hoof, A., Boogaerts, M., Van den Berghe, H. & De Wolf-Peeters, C. (1997) Further characterization of morphologically defined typical and atypical CLL: a clinical, immunophenotypic, cytogenetic and prognostic study on 390 cases. British Journal of Haematology, 97, 383391.
  • Dahlke, E., Schlag, R., Langenmayer, I., Frankenberger, M., Kafferlein, E., Subkowski, T., Emmerich, B. & Ziegler-Heitbrock, H.W. (1995) Decreased production of TNF and IL-6 in whole blood of CLL patients. American Journal of Hematology, 49, 7682.
  • Damle, R.N., Wasil, T., Fais, F., Ghiotto, F., Valetto, A., Allen, S.L., Buchbinder, A., Budman, D., Dittmar, K., Kolitz, J., Lichtman, S.M., Schulman, P., Vinciguerra, V.P., Rai, K.R., Ferrarini, M. & Chiorazzi, N. (1999) Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood, 94, 18401847.
  • Dianzani, U., Omede, P., Marmont, F., DiFranco, D., Fusaro, A., Bragardo, M., Redoglia, V., Giaretta, F., Mairone, L. & Boccadoro, M. (1994) Expansion of T cells expressing low CD4 or CD8 levels in B-cell chronic lymphocytic leukemia: correlation with disease status and neoplastic phenotype. Blood, 83, 21982205.
  • Dohner, H., Stilgenbauer, S., Benner, A., Leupolt, E., Krober, A., Bullinger, L., Dohner, K., Bentz, M. & Lichter, P. (2000) Genomic aberrations and survival in chronic lymphocytic leukemia. New England Journal of Medicine, 343, 19101916.
  • Fernandez, R.C., Lee, S.H., Fernandez, L.A., Pope, B.L. & Rozee, K.R. (1986) Production of interferon by peripheral blood mononuclear cells from normal individuals and patients with chronic lymphocytic leukemia. Journal of Interferon Research, 6, 573580.
  • Flieger, D., Emmerich, B., Meyer, N., Riethmuller, G. & Ziegler-Heitbrock, H.W. (1990) Deficient production of tumor necrosis factor by peripheral-blood monocytes in chronic lymphocytic leukemia. International Journal of Cancer, 45, 280286.
  • Foà, R. (1993) Pathogenesis of the immunodeficiency in B-cell chronic lymphocytic leukemia. In: Chronic Lymphocytic Leukemia (ed. by B.D.Cheson), pp. 147166. Marcel Dekker, Inc., New York NY, USA.
  • Foa, R., Lauria, F., Lusso, P., Giubellino, M.C., Fierro, M.T., Ferrando, M.L., Raspadori, D. & Matera, L. (1984) Discrepancy between phenotypic and functional features of natural killer T-lymphocytes in B-cell chronic lymphocytic leukaemia. British Journal of Haematology, 58, 509516.
  • Foa, R., Fierro, M.T., Lusso, P., Raspadori, D., Ferrando, M.L., Matera, L., Malavasi, F. & Lauria, F. (1986) Reduced natural killer T-cells in B-cell chronic lymphocytic leukaemia identified by three monoclonal antibodies: Leu-11, A10, AB8.28. British Journal of Haematology, 62, 151154.
  • Ford, G.S., Barnhart, B., Shone, S. & Covey, L.R. (1999) Regulation of CD154 (CD40 ligand) mRNA stability during T cell activation. Journal of Immunology, 162, 40374044.
  • Foy, T.M., Aruffo, A., Bajorath, J., Buhlmann, J.E. & Noelle, R.J. (1996) Immune regulation by CD40 and its ligand GP39. Annual Review of Immunology, 14, 591617.
  • Freeman, G.J., Boussiotis, V.A., Anumanthan, A., Bernstein, G.M., Ke, X.Y., Rennert, P.D., Gray, G.S., Gribben, J.G. & Nadler, L.M. (1995) B7-1 and B7-2 do not deliver identical costimulatory signals, since B7-2 but not B7-1 preferentially costimulates the initial production of IL-4. Immunity, 2, 523532.
  • Goddard, R.V., Prentice, A.G., Copplestone, J.A. & Kaminski, E.R. (2003) In vitro dendritic cell-induced T cell responses to B cell chronic lymphocytic leukaemia enhanced by IL-15 and dendritic cell-B-CLL electrofusion hybrids. Clinical and Experimental Immunology, 131, 8289.
  • Guarini, A., Gaidano, G., Mauro, F.R., Capello, D., Mancini, F., De Propris, M.S., Mancini, M., Orsini, E., Gentile, M., Breccia, M., Cuneo, A., Castoldi, G. & Foa, R. (2003) Chronic lymphocytic leukemia patients with highly stable and indolent disease show distinctive phenotypic and genotypic features. Blood, 102, 10351041.
  • Hart, D.N. (1997) Dendritic cells: unique leukocyte populations which control the primary immune response. Blood, 90, 32453287.
  • Kikuchi, K., Yanagawa, Y., Iwabuchi, K. & Onoe, K. (2003) Differential role of mitogen-activated protein kinases in CD40-mediated IL-12 production by immature and mature dendritic cells. Immunology Letters, 89, 149154.
  • Krackhardt, A.M., Harig, S., Witzens, M., Broderick, R., Barrett, P. & Gribben, J.G. (2002) T-cell responses against chronic lymphocytic leukemia cells: implications for immunotherapy. Blood, 100, 167173.
  • Kuchroo, V.K., Das, M.P., Brown, J.A., Ranger, A.M., Zamvil, S.S., Sobel, R.A., Weiner, H.L., Nabavi, N. & Glimcher, L.H. (1995) B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell, 80, 707718.
  • Langenkamp, A., Messi, M., Lanzavecchia, A. & Sallusto, F. (2000) Kinetics of dendritic cell activation: impact on priming of TH1, TH2 and nonpolarized T cells. Nature Immunology, 1, 311316.
  • Liu, Y.J. (2001) Dendritic cell subsets and lineages, and their functions in innate and adaptive immunity. Cell, 106, 259262.
  • Mauro, F.R., Foa, R., Giannarelli, D., Cordone, I., Crescenzi, S., Pescarmona, E., Sala, R., Cerretti, R. & Mandelli, F. (1999) Clinical characteristics and outcome of young chronic lymphocytic leukemia patients: a single institution study of 204 cases. Blood, 94, 448454.
  • Molica, S. (1994) Infections in chronic lymphocytic leukemia: risk factors, and impact on survival, and treatment. Leukemia and Lymphoma, 13, 203214.
  • Norris, D.A., Weston, W.L., Tubergen, D.G., Rose, B. & Odom, L.F. (1980) Monocyte chemotaxis in leukemia patients. Journal of Laboratory and Clinical Medicine, 95, 609615.
  • Orsini, E., Guarini, A., Chiaretti, S., Mauro, F.R. & Foa, R. (2003) The circulating dendritic cell compartment in patients with chronic lymphocytic leukemia is severely defective and unable to stimulate an effective T-cell response. Cancer Research, 63, 44974506.
  • Prieto, A., Garcia-Suarez, J., Reyes, E., Lapena, P., Hernandez, M. & Alvarez-Mon, M. (1993) Diminished DNA synthesis in T cells from B chronic lymphocytic leukemia after phytohemagglutinin, anti-CD3, and phorbol myristate acetate mitogenic signals. Experimental Hematology, 21, 15631569.
  • Ranger, A.M., Das, M.P., Kuchroo, V.K. & Glimcher, L.H. (1996) B7-2 (CD86) is essential for the development of IL-4-producing T cells. International Immunology, 8, 15491560.
  • Rasmussen, T., Hansson, L., Osterborg, A., Johnsen, H.E. & Mellstedt, H. (2003) Idiotype vaccination in multiple myeloma induced a reduction of circulating clonal tumor B cells. Blood, 101, 46074610.
  • Reid, C.D., Stackpoole, A., Meager, A. & Tikerpae, J. (1992) Interactions of tumor necrosis factor with granulocyte-macrophage colony-stimulating factor and other cytokines in the regulation of dendritic cell growth in vitro from early bipotent CD34+ progenitors in human bone marrow. Journal of Immunology, 149, 26812688.
  • Rezvany, M.R., Jeddi-Tehrani, M., Biberfeld, P., Soderlund, J., Mellstedt, H., Osterborg, A. & Rabbani, H. (2001) Dendritic cells in patients with non-progressive B-chronic lymphocytic leukaemia have a normal functional capability but abnormal cytokine pattern. British Journal of Haematology, 115, 263271.
  • Rissoan, M.C., Soumelis, V., Kadowaki, N., Grouard, G., Briere, F., de Waal Malefyt, R. & Liu, Y.J. (1999) Reciprocal control of T helper cell and dendritic cell differentiation. Science, 283, 11831186.
  • Romani, N., Gruner, S., Brang, D., Kampgen, E., Lenz, A., Trockenbacher, B., Konwalinka, G., Fritsch, P.O., Steinman, R.M. & Schuler, G. (1994) Proliferating dendritic cell progenitors in human blood. Journal of Experimental Medicine, 180, 8393.
  • Rossi, E., Matutes, E., Morilla, R., Owusu-Ankomah, K., Heffernan, A.M. & Catovsky, D. (1996) Zeta chain and CD28 are poorly expressed on T lymphocytes from chronic lymphocytic leukemia. Leukemia, 10, 494497.
  • Rozman, C. & Montserrat, E. (1995) Chronic lymphocytic leukemia. New England Journal of Medicine, 333, 10521057.
  • Ruffini, P.A., Neelapu, S.S., Kwak, L.W. & Biragyn, A. (2002) Idiotypic vaccination for B-cell malignancies as a model for therapeutic cancer vaccines: from prototype protein to second generation vaccines. Haematologica, 87, 9891001.
  • Semenzato, G., Pezzutto, A., Foa, R., Lauria, F. & Raimondi, R. (1983) T lymphocytes in B-cell chronic lymphocytic leukemia: characterization by monoclonal antibodies and correlation with Fc receptors. Clinical Immunology and Immunopathology, 26, 155161.
  • Thompson, C.B. (1995) Distinct roles for the costimulatory ligands B7-1 and B7-2 in T helper cell differentiation? Cell, 81, 979982.
  • Timmerman, J.M., Czerwinski, D.K., Davis, T.A., Hsu, F.J., Benike, C., Hao, Z.M., Taidi, B., Rajapaksa, R., Caspar, C.B., Okada, C.Y., van Beckhoven, A., Liles, T.M., Engleman, E.G. & Levy, R. (2002) Idiotype-pulsed dendritic cell vaccination for B-cell lymphoma: clinical and immune responses in 35 patients. Blood, 99, 15171526.
  • Tsukada, N., Burger, J.A., Zvaifler, N.J. & Kipps, T.J. (2002) Distinctive features of ‘‘nurselike’’ cells that differentiate in the context of chronic lymphocytic leukemia. Blood, 99, 10301037.
  • Vuillier, F., Maloum, K., Thomas, E.K., Jouanne, C., Dighiero, G. & Scott-Algara, D. (2001) Functional monocyte-derived dendritic cells can be generated in chronic lymphocytic leukaemia. British Journal of Haematology, 115, 831844.
  • Vuillier, F., Maloum, K., Thomas, E.K., Magnac, C., Dumas, G., Payelle-Brogard, B., Oppezzo, P., Dighiero, G. & Scott-Algara, D. (2003) Idiotype-pulsed dendritic cells are able to induce antitumoral cytotoxic CD8 cells in chronic lymphocytic leukaemia. British Journal of Haematology, 120, 243250.
  • Wierda, W.G., Cantwell, M.J., Woods, S.J., Rassenti, L.Z., Prussak, C.E. & Kipps, T.J. (2000) CD40-ligand (CD154) gene therapy for chronic lymphocytic leukemia. Blood, 96, 29172924.
  • Zeya, H.I., Keku, E., Richards II, F. & Spurr, C.L. (1979) Monocyte and granulocyte defect in chronic lymphocytic leukemia. American Journal of Pathology, 95, 4353.